Your browser is no longer supported. Please, upgrade your browser.
Settings
MDCO The Medicines Company daily Stock Chart
MDCO [NASD]
The Medicines Company
Index- P/E- EPS (ttm)-2.85 Insider Own0.70% Shs Outstand75.11M Perf Week-3.11%
Market Cap2.65B Forward P/E- EPS next Y-3.12 Insider Trans284.81% Shs Float70.29M Perf Month2.92%
Income-210.20M PEG- EPS next Q-0.73 Inst Own- Short Float27.95% Perf Quarter30.24%
Sales-1.63M P/S- EPS this Y51.90% Inst Trans3.62% Short Ratio17.22 Perf Half Y95.72%
Book/sh-1.01 P/B- EPS next Y-2.30% ROA-26.50% Target Price57.36 Perf Year-4.29%
Cash/sh2.69 P/C13.09 EPS next 5Y37.00% ROE824.10% 52W Range16.69 - 41.57 Perf YTD84.06%
Dividend- P/FCF- EPS past 5Y-60.50% ROI-18.20% 52W High-15.25% Beta1.09
Dividend %- Quick Ratio4.10 Sales past 5Y-60.30% Gross Margin- 52W Low111.08% ATR1.28
Employees62 Current Ratio4.10 Sales Q/Q- Oper. Margin- RSI (14)54.85 Volatility2.89% 3.56%
OptionableYes Debt/Eq- EPS Q/Q30.10% Profit Margin- Rel Volume1.63 Prev Close35.83
ShortableYes LT Debt/Eq- EarningsJul 25 BMO Payout- Avg Volume1.14M Price35.23
Recom1.50 SMA20-0.93% SMA508.25% SMA20030.50% Volume1,856,541 Change-1.67%
Apr-26-19Upgrade Goldman Neutral → Buy $25 → $55
Apr-26-19Reiterated Chardan Capital Markets Buy $85 → $90
Mar-28-19Initiated Robert W. Baird Outperform $80
Mar-21-19Initiated ROTH Capital Buy $75
Dec-14-18Initiated Wolfe Research Outperform
Dec-13-18Initiated Goldman Neutral $25
Jun-07-18Initiated B. Riley FBR, Inc. Buy $55
Jan-24-18Resumed JP Morgan Overweight $45
Oct-24-17Initiated Guggenheim Buy $45
Aug-29-17Reiterated Chardan Capital Markets Buy $80 → $85
Dec-05-16Initiated H.C. Wainwright Buy $57
Nov-16-16Reiterated RBC Capital Mkts Outperform $45 → $52
Nov-08-16Reiterated RBC Capital Mkts Outperform $48 → $45
Mar-21-16Reiterated Chardan Capital Markets Buy $50 → $65
Nov-16-15Reiterated RBC Capital Mkts Outperform $46 → $48
Nov-04-15Initiated Chardan Capital Markets Buy $50
Aug-31-15Reiterated RBC Capital Mkts Outperform $39 → $46
Aug-28-15Upgrade Jefferies Hold → Buy
Jul-06-15Upgrade Mizuho Neutral → Buy $28 → $41
Apr-10-15Reiterated Mizuho Neutral $30 → $27.50
Jun-18-19 09:58AM  Alnylam Completes Enrollment in Phase III Study of Lumasiran Zacks
Jun-17-19 07:15PM  Did Hedge Funds Drop The Ball On Medicines Company (MDCO)? Insider Monkey
Jun-13-19 12:21PM  Signal Says This Drug Stock Isn't Done Climbing Schaeffer's Investment Research
Jun-06-19 03:28PM  Alnylam Completes Rolling NDA Submission to FDA for Givosiran Zacks
Jun-04-19 12:50PM  These Bullish Medicines Company Options Trades Suggest More Upside Could Be Coming Benzinga
08:56AM  Options Traders Expect Huge Moves in Medicines Company (MDCO) Stock Zacks
Jun-03-19 04:48PM  Alnylam Initiates Phase I Study on Hypertension Candidate Zacks
06:43AM  Notable Insider Buys This Past Week: Coty, Zillow and More Benzinga
May-27-19 10:21AM  The Medicines Company Presents Clinical Data Analyses for Inclisiran at 87th European Atherosclerosis Society Congress Business Wire
May-25-19 09:31AM  Medicines Co. (MDCO) Up 17.1% Since Last Earnings Report: Can It Continue? Zacks
May-20-19 09:42AM  Medicines Company Rallies On Positive LDL Cholesterol Study Results Benzinga
09:02AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating The Medicines Company for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
May-18-19 04:50PM  New Long-Term Data Show that Twice-a-Year Dosing with Inclisiran Results in Persistent Lowering of LDL Cholesterol with No Material Safety Observations Out to Three Years Business Wire
09:04AM  What Kind Of Share Price Volatility Should You Expect For The Medicines Company (NASDAQ:MDCO)? Simply Wall St.
May-11-19 08:40AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs Benzinga
May-10-19 07:00AM  The Medicines Company to Host Investor Conference Call and Webcast During National Lipid Associations 2019 Scientific Sessions Business Wire
May-07-19 07:00AM  The Medicines Company to Participate in the Bank of America Merrill Lynch 2019 Healthcare Conference Business Wire
May-02-19 01:20PM  Did Hedge Funds Drop The Ball On The Medicines Company (MDCO) ? Insider Monkey
10:00AM  Alnylam (ALNY) Reports Narrower-Than-Expected Loss in Q1 Zacks
May-01-19 10:03AM  4 Strong Buy Stocks With Plenty Of Upside Ahead TipRanks
Apr-29-19 02:55PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating The Medicines Company for Potential Breaches Of Fiduciary Duty By Its Board of Directors ACCESSWIRE
02:41AM  Edited Transcript of MDCO earnings conference call or presentation 25-Apr-19 12:30pm GMT Thomson Reuters StreetEvents
Apr-26-19 11:11AM  Medicines Company (MDCO) Q1 Loss Narrows, Inclisiran in Focus Zacks +5.97%
08:35AM  Medicines Co.: 1Q Earnings Snapshot Associated Press
07:29AM  Medicines Co (MDCO) Q1 2019 Earnings Call Transcript Motley Fool
Apr-25-19 07:00AM  The Medicines Company Reports First-Quarter 2019 Financial Results and Significant Progress with the Inclisiran Clinical Development Program Business Wire
Apr-18-19 07:00AM  The Medicines Company to Announce First Quarter 2019 Financial Results on April 25 Business Wire
Apr-17-19 10:32AM  Medicines Co. (MDCO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-16-19 07:13PM  Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran Zacks
Apr-15-19 04:49PM  Alnylam (ALNY) Reports Phase III ENVISION Data on Givosiran Zacks
Apr-12-19 08:49AM  Implied Volatility Surging for Medicines Company (MDCO) Stock Options Zacks
Mar-18-19 06:51PM  Alnylam's (ALNY) Impressive Pipeline Drives Share Price Zacks
Mar-15-19 04:24PM  Can Amgen Leapfrog A Key Rival And Add Millions Of New Patients? Investor's Business Daily
Mar-12-19 10:18AM  Implied Volatility Surging for Medicines Company (MDCO) Stock Options Zacks
09:59AM  Alnylam Files Application for Hypertension Candidate in UK Zacks
09:23AM  Edited Transcript of MDCO earnings conference call or presentation 27-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Mar-10-19 07:14PM  Insider Buys Of The Week: Arconic, CenturyLink, Hain Celestial and More Benzinga
Mar-08-19 04:32PM  Could A Patent Battle Force Sanofi To Snap Up This Biotech Stock? Investor's Business Daily
02:51PM  If You Had Bought Medicines (NASDAQ:MDCO) Stock A Year Ago, Youd Be Sitting On A 28% Loss, Today Simply Wall St.
08:59AM  Insider Buying Is Still Alive and Well at These 3 Companies TheStreet.com
02:08AM  [$$] A disease in remission? New hope in the quest to cure HIV Financial Times
Mar-07-19 09:00AM  Alnylam Stock Down Despite Positive Phase III Givosiran Data Zacks
Feb-28-19 09:50AM  Medicines Company (MDCO) Q4 Loss Widens, Inclisiran in Focus Zacks
Feb-27-19 12:57PM  Medicines Co (MDCO) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:00AM  The Medicines Company Reports Fourth-Quarter and Full Year 2018 Business and Financial Results Business Wire
Feb-21-19 07:00AM  The Medicines Company Announces Upcoming Investor Conference Presentations Business Wire
Feb-20-19 07:00AM  The Medicines Company to Announce Fourth-Quarter and Full-Year 2018 Financial Results on February 27 Business Wire
Feb-13-19 10:31AM  Will Medicines Co. (MDCO) Report Negative Q4 Earnings? What You Should Know Zacks
Feb-08-19 08:54AM  Is the Options Market Predicting a Spike in Medicines Company (MDCO) Stock? Zacks
07:50AM  [$$] FT Health: Combating cancer; Brexit and EU medicine verification Financial Times
07:47AM  Alnylam's (ALNY) Q4 Earnings and Revenues Beat Estimates Zacks
Feb-01-19 06:47AM  [$$] FT Health: Is Big Food ripe for the Big Tobacco treatment? Financial Times
Jan-30-19 08:10AM  Factors of Influence in 2019, Key Indicators and Opportunity within Leidos, Nomad Foods, Huron Consulting Group, Casella Waste, The Medicines, and Aurinia Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
Jan-28-19 01:11AM  [$$] UK shows leadership on anti-microbial resistance Financial Times
Jan-22-19 02:38PM  Need To Know: The Medicines Company (NASDAQ:MDCO) Insiders Have Been Buying Shares Simply Wall St.
Jan-18-19 05:00AM  Top Picks 2019- The Medicines Company MDCO MoneyShow
Jan-07-19 07:30AM  The Medicines Company Announces 5th Review of Un-blinded Data and Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase 3 Trials Business Wire
Jan-04-19 05:00AM  [$$] British schools explore EU expansion after Brexit Financial Times
Jan-03-19 08:42AM  Implied Volatility Surging for Medicines Company (MDCO) Stock Options Zacks
Dec-24-18 09:29AM  Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III Zacks
Dec-23-18 09:42AM  Insider Buys Of The Week: Chesapeake Energy, Medicines Company, NuStar Energy Benzinga
Dec-18-18 06:15PM  The Medicines Co (MDCO) CEO Mark Timney Bought $499,652 of Shares GuruFocus.com
Dec-13-18 10:52PM  Is The Medicines Company (MDCO) A Good Stock To Buy? Insider Monkey -14.50%
09:43PM  The Medicines Company Prices $150 Million of Convertible Notes Business Wire
05:37PM  Here's Why Shares of The Medicines Company Sank 14.5% Today Motley Fool
Dec-12-18 04:30PM  The Medicines Company Announces Intention to Offer $150 Million of Convertible Notes Business Wire +11.64%
Dec-11-18 07:28AM  The Medicines Co. names Mark Timney CEO effective immediately MarketWatch
07:23AM  The Medicines Company Appoints Mark Timney as Chief Executive Officer Business Wire
Dec-08-18 09:30AM  Medicines Co. (MDCO) Down 11% Since Last Earnings Report: Can It Rebound? Zacks
Dec-06-18 11:29PM  [$$] Health sector warned of 6-month medicine shortages in no-deal Financial Times
Dec-04-18 03:36AM  [$$] Government prepares to ration ferry space under no-deal Brexit Financial Times
Dec-03-18 11:00PM  [$$] Flexibility on cancer drugs approval will foster innovation Financial Times
Nov-21-18 11:03PM  [$$] The Brexit political declaration: the key points Financial Times
Nov-20-18 09:51PM  Edited Transcript of MDCO earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-19-18 04:46AM  [$$] Pharma leaders warn Brexit deal lacks detail needed for patient safety Financial Times
Nov-14-18 11:36PM  [$$] Business horrified by UK political turmoil over Brexit Financial Times -8.77%
Nov-12-18 10:22AM  Medicines Company (MDCO) Q3 Loss Widens, Inclisiran in Focus Zacks -6.09%
Nov-09-18 10:15AM  Company Profile for The Medicines Company Business Wire
Nov-08-18 09:39AM  Alnylam's (ALNY) Q3 Loss Narrower Than Expected, Sales Miss Zacks -6.44%
09:20AM  Medicines Co. (MDCO) Reports Q3 Loss, Lags Revenue Estimates Zacks
08:13AM  Medicines Co.: 3Q Earnings Snapshot Associated Press
07:00AM  The Medicines Company Reports Third-Quarter 2018 Results Business Wire
Nov-05-18 07:40AM  Report: Exploring Fundamental Drivers Behind SkyWest, Blueprint Medicines, HP, Hewlett Packard Enterprise, Cardinal Health, and The Medicines New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-01-18 07:00AM  The Medicines Company to Announce Third-Quarter 2018 Financial Results on November 8 Business Wire +8.08%
Oct-30-18 10:34PM  [$$] UK drugmaker ITH Pharma charged after baby deaths Financial Times
Oct-29-18 05:39AM  [$$] Budget 2018: The chancellors speech Financial Times
Oct-22-18 04:26PM  [$$] Medicines Co. Spinout Qpex Biopharma Raises $33 Million Series A The Wall Street Journal
Oct-19-18 09:29AM  Mallinckrodt (MNK) Gets $26 Million as Funding From BARDA Zacks
Oct-15-18 09:10AM  Investor Expectations to Drive Momentum within Fossil Group, The Medicines, BWX Technologies, PVH, Group 1 Automotive, and Assurant Discovering Underlying Factors of Influence GlobeNewswire
Oct-03-18 10:20PM  [$$] Drugs regulator warns on no-deal Brexit access to new medicines Financial Times
11:37AM  Medicines Company to Continue Inclisiran Studies as Planned Zacks
Oct-01-18 07:00AM  The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following Fourth Review of Unblinded Data Business Wire
Sep-28-18 12:00AM  [$$] Paris warns of threat to EU banking watchdogs relocation plans Financial Times
Sep-24-18 02:28AM  [$$] Brexit fears ease over supplies of UK drugs to Europe Financial Times
Sep-17-18 08:51AM  Are Options Traders Betting on a Big Move in Medicines Company (MDCO) Stock? Zacks
Sep-06-18 05:34PM  5 Stocks With Low Price-Sales Ratios GuruFocus.com
Aug-31-18 10:24AM  Why Is Medicines Co. (MDCO) Up 2.7% Since Last Earnings Report? Zacks
Aug-17-18 01:00AM  [$$] Opinion today: Africas demographic destiny Financial Times
Aug-16-18 10:09PM  [$$] FT Health: Vaping debate heats up Financial Times
12:01AM  [$$] Amsterdam house price surge stoked by nationwide shortage of homes Financial Times
The Medicines Company, a biopharmaceutical company, focuses on developing therapeutics for the treatment of therosclerotic cardiovascular disease. The company is developing Inclisiran, an investigational RNA interference therapeutic that inhibits production of proprotein convertase subtilisin/kexin type 9, which controls LDL-cholesterol levels. It has collaboration agreement with Alnylam Pharmaceuticals, Inc. The Medicines Company was founded in 1996 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENNER ALEXANDER JDirectorMay 30Buy34.8150,0001,740,5004,152,000May 31 07:31 AM
DENNER ALEXANDER JDirectorMay 29Buy34.8535,0001,219,7504,102,000May 31 07:31 AM
DENNER ALEXANDER JDirectorMay 22Buy33.13139,0004,605,0704,067,000May 22 05:56 PM
DENNER ALEXANDER JDirectorMay 21Buy33.95132,0004,481,4003,928,000May 22 05:56 PM
DENNER ALEXANDER JDirectorMay 20Buy34.50160,0005,520,0003,796,000May 22 05:56 PM
DENNER ALEXANDER JDirectorMar 06Buy24.91248,1006,180,1713,636,000Mar 08 01:13 PM
DENNER ALEXANDER JDirectorMar 05Buy26.07181,9004,742,1333,387,900Mar 05 05:14 PM
DENNER ALEXANDER JDirectorMar 04Buy25.45325,0008,271,2503,206,000Mar 05 05:14 PM
DENNER ALEXANDER JDirectorMar 01Buy25.15100,0002,515,0002,881,000Mar 05 05:14 PM
Timney MarkChief Executive OfficerDec 21Buy17.902,92652,37529,789Dec 27 01:45 PM
DENNER ALEXANDER JDirectorDec 20Buy17.8910,000178,9002,781,000Dec 21 07:30 AM
Cox Christopher TEVP & Chief Corp. Dev. OfficerDec 20Buy17.70113,5002,008,950334,955Dec 21 07:22 AM
DENNER ALEXANDER JDirectorDec 18Buy18.1810,000181,8002,771,000Dec 18 04:16 PM
Timney MarkChief Executive OfficerDec 17Buy18.6026,863499,65226,863Dec 18 04:36 PM
DENNER ALEXANDER JDirectorDec 17Buy17.9120,000358,2002,761,000Dec 18 04:16 PM
DENNER ALEXANDER JDirectorDec 14Buy18.97219,0004,154,4302,741,000Dec 17 04:21 PM
DENNER ALEXANDER JDirectorDec 13Buy20.73600,00012,438,0002,522,000Dec 17 04:21 PM
Cox Christopher TEVP & Chief Corp. Dev. OfficerNov 16Buy19.7350,300992,419221,455Nov 19 07:55 AM
MEANWELL CLIVECEOSep 04Sale39.3150,0001,965,500302,409Sep 05 06:27 PM
MEANWELL CLIVECEOAug 01Sale39.2450,0001,962,000352,034Aug 02 05:56 PM
MEANWELL CLIVECEOJul 02Sale36.0750,0001,803,500402,034Jul 05 04:53 PM